Medtronic (MDT) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Medtronic Revenue Highlights

Latest Revenue (Y)

$33.54B

Latest Revenue (Q)

$8.29B

Main Segment (Y)

Cardiac and Vascular Group

Main Geography (Y)

UNITED STATES

Medtronic Revenue by Period

Medtronic Revenue by Year

Date	Revenue	Change
2025-04-25	$33.54B	3.62%
2024-04-26	$32.36B	3.64%
2023-04-28	$31.23B	-1.45%
2022-04-29	$31.69B	5.21%
2021-04-30	$30.12B	4.16%
2020-04-24	$28.91B	-5.38%
2019-04-26	$30.56B	2.02%
2018-04-27	$29.95B	0.82%
2017-04-28	$29.71B	3.04%
2016-04-29	$28.83B	42.31%
2015-04-24	$20.26B	19.15%
2014-04-30	$17.00B	2.50%
2013-04-30	$16.59B	2.51%
2012-04-30	$16.18B	1.58%
2011-04-30	$15.93B	0.73%
2010-04-30	$15.82B	8.34%
2009-04-30	$14.60B	8.02%
2008-04-30	$13.52B	9.89%
2007-04-30	$12.30B	8.92%
2006-04-30	$11.29B	12.31%
2005-04-30	$10.05B	10.65%
2004-04-30	$9.09B	18.55%
2003-04-30	$7.67B	19.57%
2002-04-30	$6.41B	15.47%
2001-04-30	$5.55B	10.71%
2000-04-30	$5.01B	21.30%
1999-04-30	$4.13B	58.71%
1998-04-30	$2.60B	6.83%
1997-04-30	$2.44B	12.41%
1996-04-30	$2.17B	24.49%
1995-04-30	$1.74B	25.27%
1994-04-30	$1.39B	-

Medtronic generated $33.54B in revenue during NA 2025, up 3.62% compared to the previous quarter, and up 115.99% compared to the same period a year ago.

Medtronic Revenue by Quarter

Date	Revenue	Change
2025-01-24	$8.29B	-1.32%
2024-10-25	$8.40B	6.17%
2024-07-26	$7.92B	-7.85%
2024-04-26	$8.59B	6.18%
2024-01-26	$8.09B	1.32%
2023-10-27	$7.98B	3.66%
2023-07-28	$7.70B	-9.85%
2023-04-28	$8.54B	10.57%
2023-01-27	$7.73B	1.87%
2022-10-28	$7.58B	2.90%
2022-07-29	$7.37B	-8.88%
2022-04-29	$8.09B	4.20%
2022-01-28	$7.76B	-1.07%
2021-10-29	$7.85B	-1.75%
2021-07-30	$7.99B	-2.45%
2021-04-30	$8.19B	5.31%
2021-01-29	$7.78B	1.67%
2020-10-30	$7.65B	17.52%
2020-07-31	$6.51B	8.49%
2020-04-24	$6.00B	-22.28%
2020-01-24	$7.72B	0.14%
2019-10-25	$7.71B	2.84%
2019-07-26	$7.49B	-8.02%
2019-04-26	$8.15B	7.95%
2019-01-25	$7.55B	0.87%
2018-10-26	$7.48B	1.31%
2018-07-27	$7.38B	-9.33%
2018-04-27	$8.14B	10.52%
2018-01-26	$7.37B	4.52%
2017-10-27	$7.05B	-4.60%
2017-07-28	$7.39B	-6.64%
2017-04-28	$7.92B	8.69%
2017-01-27	$7.28B	-0.84%
2016-10-28	$7.34B	2.50%
2016-07-29	$7.17B	-5.30%
2016-04-29	$7.57B	9.13%
2016-01-29	$6.93B	-1.76%
2015-10-30	$7.06B	-2.97%
2015-07-31	$7.27B	-0.41%
2015-04-24	$7.30B	69.15%
2015-01-23	$4.32B	-1.10%
2014-10-31	$4.37B	2.18%
2014-07-31	$4.27B	-6.40%
2014-04-30	$4.57B	9.66%
2014-01-31	$4.16B	-0.74%
2013-10-31	$4.19B	2.72%
2013-07-31	$4.08B	-8.45%
2013-04-30	$4.46B	10.75%
2013-01-31	$4.03B	-1.66%
2012-10-31	$4.09B	2.17%
2012-07-31	$4.01B	-6.73%
2012-04-30	$4.30B	9.67%
2012-01-31	$3.92B	-5.18%
2011-10-31	$4.13B	2.05%
2011-07-31	$4.05B	-5.73%
2011-04-30	$4.29B	8.43%
2011-01-31	$3.96B	1.49%
2010-10-31	$3.90B	3.45%
2010-07-31	$3.77B	-10.08%
2010-04-30	$4.20B	8.96%
2010-01-31	$3.85B	0.34%
2009-10-31	$3.84B	-2.42%
2009-07-31	$3.93B	2.72%
2009-04-30	$3.83B	9.59%
2009-01-31	$3.49B	-2.13%
2008-10-31	$3.57B	-3.67%
2008-07-31	$3.71B	-3.99%
2008-04-30	$3.86B	13.36%
2008-01-31	$3.40B	-

Medtronic generated $8.29B in revenue during Q3 2025, up -1.32% compared to the previous quarter, and up 103.86% compared to the same period a year ago.

Medtronic Revenue Breakdown

Medtronic Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Apr 25	Apr 24	Apr 23	Apr 22	Apr 21
Cardiac and Vascular Group	$12.48B	$11.83B	$11.57B	-	-
Neuroscience Group	$9.85B	$9.41B	$8.96B	-	-
Medical Surgical	$8.41B	$8.42B	$8.43B	-	-
Diabetes Group	$2.75B	$2.49B	$2.26B	-	-
Cardiovascular	-	-	$11.57B	$5.54B	-
Diabetes Operating Unit	-	-	$2.26B	-	-
Medical Surgical Portfolio	-	-	$8.43B	$3.86B	$3.65B
Neuroscience Portfolio	-	-	$8.96B	$5.75B	$5.46B
Cardiovascular Portfolio	-	-	-	-	$141.00M

Medtronic's latest annual revenue breakdown by segment (product or service), as of Apr 25: Cardiac and Vascular Group (37.27%), Neuroscience Group (29.40%), Medical Surgical (25.10%), and Diabetes Group (8.23%).

Quarterly Revenue by Product

Product/Service	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20
Diabetes Group	$728.00M	$694.00M	$686.00M	$647.00M	$947.00M	$963.00M	$1.16B	-	-	-	-	-	-	-	-	-	-	-	-	-
Cardiac and Vascular Group	$3.33B	$3.04B	$3.10B	$3.01B	$6.06B	$1.27B	$1.38B	$1.21B	$880.00M	$1.37B	-	-	-	-	-	-	-	-	-	-
Neuroscience Group	$2.62B	$2.46B	$2.45B	$2.32B	$4.90B	$2.29B	$4.44B	$1.51B	$1.51B	$1.42B	$1.40B	$1.39B	$1.45B	-	-	-	-	-	-	-
Medical Surgical	$2.21B	$2.07B	$2.13B	$2.00B	$4.24B	$2.14B	$4.08B	$965.00M	$905.00M	$843.00M	$990.00M	$970.00M	$990.00M	-	-	-	-	-	-	-
Cardiovascular	-	-	-	-	-	$2.92B	$5.70B	$9.23B	$1.38B	$1.42B	$1.30B	$1.46B	$1.30B	$1.37B	$1.42B	-	-	-	-	-
Other	-	-	-	-	-	$22.00M	$32.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Minimally Invasive Therapies Group	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$959.00M	$996.00M	$722.00M	$763.00M	$934.00M
Restorative Therapies Group	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$1.40B	$1.40B	$1.14B	$935.00M	$1.41B

Medtronic's latest quarterly revenue breakdown by segment (product or service), as of Apr 25: Cardiac and Vascular Group (37.50%), Neuroscience Group (29.46%), Medical Surgical (24.86%), and Diabetes Group (8.19%).

Medtronic Revenue Breakdown by Country

Annual Revenue by Country

Country	Apr 25	Apr 24	Apr 23	Apr 22	Apr 21
UNITED STATES	$17.17B	-	-	-	-
IRELAND	$116.00M	$98.00M	$101.00M	$100.00M	-
Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea	-	$5.82B	$5.45B	-	-
Japan, Australia, New Zealand, Korea, Canada, and Western Europe	-	$9.98B	$9.41B	-	-
Total Other Countries, Excluding Ireland	-	-	$31.13B	$31.59B	$30.02B
Total Other Countries, Excluding United States and Ireland	-	-	$14.76B	$15.45B	$14.49B
Medical Surgical Portfolio	-	-	-	$3.86B	-
Cardiovascular	-	-	-	$5.54B	-
Neuroscience Portfolio	-	-	-	$5.75B	-

Medtronic's latest annual revenue breakdown by geography, as of Apr 25: UNITED STATES (99.33%), and IRELAND (0.67%).

Quarterly Revenue by Country

Country	Apr 25	Jan 25	Oct 24	Jul 24	Apr 24	Oct 23	Jul 23	Apr 23	Jan 23	Oct 22	Jul 22	Apr 22	Jan 22	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20
UNITED STATES	$4.55B	$4.24B	$4.30B	$4.08B	$4.18B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
IRELAND	$29.00M	$28.00M	$29.00M	$30.00M	$29.00M	$29.00M	$27.00M	$23.00M	$25.00M	$23.00M	$25.00M	$24.00M	$27.00M	$26.00M	$26.00M	$25.00M	$24.00M	$24.00M	$19.00M	-
Total Other Countries, Excluding United States and Ireland	$4.35B	$3.78B	$3.75B	$4.04B	$3.64B	$3.49B	$3.58B	$3.97B	$3.80B	$3.82B	$3.86B	$3.98B	$3.81B	$3.57B	$3.13B	$3.13B	-	-	-	-
Middle East, Africa, Latin America, Eastern Europe, and Asia, Excluding Japan and Korea	-	-	-	-	$3.07B	$1.44B	$1.33B	-	-	-	-	-	-	-	-	-	-	-	-	-
Japan, Australia, New Zealand, Korea, Canada, and Western Europe	-	-	-	-	$5.15B	$2.37B	$2.67B	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Other Countries, Excluding Ireland	-	-	-	-	-	$7.96B	$7.67B	$8.52B	$7.70B	$7.56B	$7.35B	$8.06B	$7.74B	$7.82B	$7.96B	$8.16B	$7.75B	$7.62B	$6.48B	$5.98B
Cardiovascular	-	-	-	-	-	-	-	-	$1.38B	-	-	-	-	-	-	-	-	-	-	-
Medical Surgical	-	-	-	-	-	-	-	-	$965.00M	-	-	-	-	-	-	-	-	-	-	-
Neuroscience Group	-	-	-	-	-	-	-	-	$1.51B	-	-	-	-	-	-	-	-	-	-	-

Medtronic's latest quarterly revenue breakdown by geography, as of Apr 25: UNITED STATES (50.95%), Total Other Countries, Excluding United States and Ireland (48.73%), and IRELAND (0.32%).

Medtronic Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
ABT	Abbott Laboratories	$41.95B	$10.36B
MDT	Medtronic	$33.54B	$8.29B
SYK	Stryker	$22.59B	$5.87B
BSX	Boston Scientific	$16.75B	$4.66B
EW	Edwards Lifesciences	$5.44B	$1.41B
ALGN	Align	$4.00B	$979.26M
DXCM	DexCom	$3.62B	$1.04B
PODD	Insulet	$2.07B	$597.50M
ZBH	Zimmer Biomet	$2.02B	$1.91B
TNDM	Tandem Diabetes Care	$940.20M	$234.42M

MDT Revenue FAQ

What is Medtronic’s yearly revenue?

Medtronic's yearly revenue for 2025 was $33.54B, representing an increase of 3.62% compared to 2024. The company's yearly revenue for 2024 was $32.36B, representing an increase of 3.64% compared to 2023. MDT's yearly revenue for 2023 was $31.23B, representing a decrease of -1.45% compared to 2022.

What is Medtronic’s quarterly revenue?

Medtronic's quarterly revenue for Q3 2025 was $8.29B, a -1.32% decrease from the previous quarter (Q2 2025), and a 2.51% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $8.4B, a 6.17% increase from the previous quarter (Q1 2025), and a 5.25% increase year-over-year (Q2 2024). MDT's quarterly revenue for Q1 2025 was $7.92B, a -7.85% decrease from the previous quarter (Q4 2024), and a 2.77% increase year-over-year (Q1 2024).

What is Medtronic’s revenue growth rate?

Medtronic's revenue growth rate for the last 3 years (2023-2025) was 7.40%, and for the last 5 years (2021-2025) was 11.36%.

What are Medtronic’s revenue streams?

Medtronic's revenue streams in r 25 are Cardiac and Vascular Group, Neuroscience Group, Medical Surgical, and Diabetes Group. Cardiac and Vascular Group generated $12.48B in revenue, accounting 37.27% of the company's total revenue, up 5.49% year-over-year. Neuroscience Group generated $9.85B in revenue, accounting 29.40% of the company's total revenue, up 4.68% year-over-year. Medical Surgical generated $8.41B in revenue, accounting 25.10% of the company's total revenue, down -0.12% year-over-year. Diabetes Group generated $2.76B in revenue, accounting 8.23% of the company's total revenue, up 10.73% year-over-year.

What is Medtronic’s main source of revenue?

For the fiscal year ending Apr 25, the largest source of revenue of Medtronic was Cardiac and Vascular Group. This segment made a revenue of $12.48B, representing 37.27% of the company's total revenue.